Oppenheimer & CO Inc Applied Therapeutics Inc. Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$29.41 - $51.23 $2.17 Million - $3.78 Million	-73,783 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$19.54 - $55.47 $390,800 - $1.11 Million	-20,000 Reduced 21.33%	73,783 $2.41 Million
Q4 2019 Feb 07, 2020	BUY	$10.16 - $28.14 $952,835 - $2.64 Million	93,783 New	93,783 $2.56 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $442M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.